Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBuying Mounjaro in advance is not straightforward in the UK, and that is intentional. Mounjaro is a prescription-only medicine, which means a qualified prescriber must assess your health before any supply — including repeat or future supply. You cannot stockpile it the way you might a vitamin. That said, there are legitimate ways to plan ahead and avoid gaps in your treatment, and understanding the legal route makes all the difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is a Prescription-Only Medicine under UK law, which means every supply must be authorised by a prescriber following a clinical assessment of your current health. A prescription covers a defined supply, usually one pen at a time, dispensed per the treatment schedule your prescriber sets. Issuing a prescription for pens that have no clinical basis at the time of writing would breach UK prescribing standards, so a responsible prescriber will not do it.
This is worth sitting with for a moment. If you are asking this question, you have probably experienced the mild dread of a pen running low and no clarity on what happens next. That is a very reasonable concern, not a sign you are doing anything wrong. The answer is not stockpiling; it is building a reliable repeat process with a pharmacy that turns around approvals quickly.
Pharmacies that offer to sell you several months' worth upfront, with minimal review, are a significant red flag. MHRA safety communications have repeatedly warned that fake weight-loss pens are circulating in the UK (some containing insulin rather than tirzepatide) and sellers without proper clinical oversight are one of the main channels through which counterfeit products enter the supply chain. Report any suspect seller via the Yellow Card scheme.
At a regulated pharmacy, the practical solution is timing your repeat request correctly. With once-weekly dosing, each Mounjaro pen contains four doses, covering four weeks. Submitting your next repeat request before your current pen is exhausted means a clinician can review it, it can be approved, dispatched and delivered before you run out.
At nume, a prescriber reviews every repeat order before it is dispensed. That review covers your progress, any side effects you have experienced, and whether your current dose remains appropriate. It is a genuine clinical check, not a rubber stamp. Orders placed before 12pm on a working day are dispatched the same day once approved, and DPD delivers free the next working day. In practice, a repeat ordered on a Monday morning typically arrives Tuesday. Ordering through a regulated online pharmacy like this is the closest thing to planning ahead that the legal framework allows.
If you are moving from another provider and want to continue without a gap, transferring your treatment to a new pharmacy is possible, you will need to provide evidence of your current dose and recent treatment history, which our prescribers review before approving continuation.
NHS access to Mounjaro follows a phased rollout under NICE's recommendation (TA1026). As of mid-2026, eligibility on the NHS requires a BMI of 40 or above plus four or more qualifying conditions from a defined list, with criteria expanding in phases over the coming years. Even where eligible, patients receive treatment through commissioned services with their own prescribing and dispensing protocols, batch dispensing for individual advance stockpiling is not standard practice.
Private prescribing through a GPhC-registered pharmacy follows the same one-pen-per-valid-prescription principle. NHS versus private access differs mainly in eligibility thresholds and waiting times, not in the underlying prescription law that governs supply.
Any online pharmacy operating legally in the UK must be registered with the General Pharmaceutical Council. You can check any pharmacy's registration on the GPhC register, search by name or registration number. nume's GPhC premises registration is 9012878, verifiable directly at that link. A legitimate pharmacy will have a registered prescriber, identity verification, and a clinical consultation before any prescription is issued.
Sellers on social media or third-party marketplaces, or those offering Mounjaro without any clinical assessment, are operating outside UK law. The MHRA has confirmed that counterfeit tirzepatide pens have been seized in the UK, including from an illicit manufacturing site. If you want to buy Mounjaro through a legitimate route, the safest check is simple: is the pharmacy on the GPhC register? If not, do not order. If you are unsure about a seller, our guide to sourcing Mounjaro safely covers what to look for and what to avoid.
Ready to start or continue your treatment through a pharmacy you can verify? Before placing an order, you may also find it helpful to read about who can buy Mounjaro, so you know what eligibility criteria a prescriber will consider during your consultation. Start your free consultation and a GPhC-registered prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.